{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:24:19Z","timestamp":1790688259295,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ando.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:28:46Z","timestamp":1583321326000},"page":"146-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular complications of lipodystrophic syndromes \u2013 focus on laminopathies"],"prefix":"10.1016","volume":"82","author":[{"given":"Helena","family":"Mosbah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Donadille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Wahbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2020.03.002_bib0160","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib2160","first-page":"30234","article-title":"Lipodystrophic syndromes: From diagnosis to treatmen","volume":"4266","author":"Sollier","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2020.03.002_bib0165","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/jc.2018-02730","article-title":"Comorbidities and survival in patients with lipodystrophy: an International Chart Review Study","volume":"104","author":"Akinci","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0170","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/01.CIR.103.18.2225","article-title":"Premature atherosclerosis associated with monogenic insulin resistance","volume":"103","author":"Hegele","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2020.03.002_bib0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00431-019-03521-6","article-title":"Neonatal cardiac hypertrophy: the role of hyperinsulinism-a review of literature","volume":"179","author":"Paauw","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ando.2020.03.002_bib0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13098-019-0444-8","article-title":"Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in young patients with congenital generalized lipodystrophy","volume":"11","author":"Ponte","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.ando.2020.03.002_bib0185","doi-asserted-by":"crossref","DOI":"10.1042\/BST20190380","article-title":"Lessons from cavin-1 deficiency","author":"Liu","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ando.2020.03.002_bib0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diabet.2018.09.006","article-title":"Cardiometabolic assessment of lamin A\/C gene mutation carriers: a phenotype-genotype correlation","volume":"45","author":"Kwapich","year":"2019","journal-title":"Diab Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0195","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.2999","article-title":"Nuclear lamins and laminopathies","volume":"226","author":"Worman","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.ando.2020.03.002_bib0200","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","article-title":"New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome","volume":"92","author":"Decaudain","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2020.03.002_bib0210","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1242\/dmm.006346","article-title":"LMNA cardiomyopathy: cell biology and genetics meet clinical medicine","volume":"4","author":"Lu","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.ando.2020.03.002_bib0215","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ando.2020.03.002_bib0220","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson-Gilford progeria syndrome: review of the phenotype","volume":"140","author":"Hennekam","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ando.2020.03.002_bib0225","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.59.4.620","article-title":"Lamin A\/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy","volume":"59","author":"Van der Kooi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ando.2020.03.002_bib0230","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9343(02)01070-7","article-title":"Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A\/C gene","volume":"112","author":"Garg","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2020.03.002_bib0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0004.2009.01350.x","article-title":"Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A\/C mutations","volume":"78","author":"Subramanyam","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.ando.2020.03.002_bib0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ahj.2014.12.021","article-title":"Metabolic and cardiac phenotype characterization in 37 atypical Dunnigan patients with nonfarnesylated mutated prelamin A","volume":"169","author":"Andre","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ando.2020.03.002_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.repc.2016.07.018","article-title":"Complex phenotype linked to a mutation in exon 11 of the lamin A\/C gene: hypertrophic cardiomyopathy, atrioventricular block, severe dyslipidemia and diabetes","volume":"36","author":"Francisco","year":"2017","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.ando.2020.03.002_bib0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2265.2007.03146.x","article-title":"A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy","volume":"69","author":"Ara\u00fajo-Vilar","year":"2008","journal-title":"Clin Endocrino (Oxf)"},{"key":"10.1016\/j.ando.2020.03.002_bib0255","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0260","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1210\/jc.2009-0472","article-title":"Atypical progeroid syndrome due to heterozygous missense LMNA mutations","volume":"94","author":"Garg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0265","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1210\/jc.2017-02078","article-title":"A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNAp.T10I mutation","volume":"103","author":"Hussain","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.0000136392.59656.8b","article-title":"Laminopathies and atherosclerosis","volume":"24","author":"Al-Shali","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ando.2020.03.002_bib0275","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/hmg\/ddy055","article-title":"The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T\/Brachyury and early vascular differentiation gene networks","volume":"27","author":"Briand","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2020.03.002_bib0280","first-page":"4","article-title":"Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies","author":"Brayson","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ando.2020.03.002_bib0285","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2015.12.012","article-title":"LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: role of ZMPSTE24 downregulation","volume":"245","author":"Afonso","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ando.2020.03.002_bib0290","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/hmg\/ddw090","article-title":"ERK1\/2 directly acts on CTGF\/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A\/C gene","volume":"25","author":"Chatzifrangkeskou","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2020.03.002_bib0295","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2020.03.002_bib0300","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/en.2015-1624","article-title":"Effect of leptin replacement on PCSK9 in ob\/ob mice and female lipodystrophic patients","volume":"157","author":"Levenson","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2020.03.002_bib0305","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.diabet.2016.08.004","article-title":"One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes","volume":"43","author":"Vatier","year":"2017","journal-title":"Diab Metab"},{"key":"10.1016\/j.ando.2020.03.002_bib0310","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/js.2019-00103","article-title":"Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy","volume":"3","author":"Kinzer","year":"2019","journal-title":"J Endocr Soc"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:52:46Z","timestamp":1757717566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620300378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":32,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0003426620300378"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular complications of lipodystrophic syndromes \u2013 focus on laminopathies","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}